This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A market index tracks a group of assets, while a benchmark measures performance against a standard. Understand their roles and limits.
27,218 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Voters in California face a pivotal choice on a billionaire wealth tax and new limits on local transfer taxes as hous...
Oracle stock crashed again as investors reassess AI-related spend and OpenAI exposure. The pullback may create a buyi...
A historic clash over openness in software mirrors today’s AI debate, with investors watching who controls code, data...
Memory demand tied to AI and data centers has Micron at a pivotal moment. This guide breaks down whether micron stock...
In 2026, investors face a choice between a pure digital disruptor in LatAm and a large US consumer lender with a heav...
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...
Alibaba leads a broad rally in China’s tech and e-commerce sector as investors brace for quarterly results. Baidu and...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
A landmark civil suit over ownership of long-dormant Bitcoin addresses has narrowed, with key defendants exiting as o...
Two popular paths into gold—the direct bullion route and a miners-focused fund—each offer distinct risks and rewards....
The Trump Accounts program promises big future wealth for kids, but financial experts caution that projected outcomes...